Pfizer Ltd.
Snapshot View

4250.00 +48.35 ▲1.2%

12 August 2022, 04:01:00 PM
Volume: 2,322

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pfizerltd.co.in
Market Cap 19,302.57 Cr.
Enterprise Value(EV) 17,671.74 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 97.32 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 43.36 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 633.25 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.66 Calculated using Price: 4,219.35
Dividend Yield 0.83 Period Ending 2022-03
No. of Shares Subscribed 4.57 Cr. 45,747,732 Shares
FaceValue 10
Company Profile
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.15%
1 Week
+1.40%
1 Month
+3.51%
3 Month
+0.87%
6 Month
-4.49%
1 Year
-26.98%
2 Year
-6.53%
5 Year
+137.87%
10 Year
+242.12%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.77 5.31 14.75 14.70 14.11 15.07 15.89 17.19 23.30
Return on Capital Employed (%) 28.96 15.87 22.78 22.62 21.49 23.22 20.38 23.62 29.78
Return on Assets (%) 14.91 4.00 11.22 10.95 10.36 11.25 12.20 13.00 17.24

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1,694 658 1,973 2,164 2,419 2,683 3,011 3,395 2,393 2,864
Non Curr. Liab. -26 -19 -35 66 62 52 37 136 85 136
Curr. Liab. 351 303 609 658 780 954 892 873 774 853
Minority Int.
Equity & Liab. 2,020 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854
Non Curr. Assets 215 257 1,295 1,256 1,210 1,273 1,225 1,357 1,344 1,457
Curr. Assets 1,804 686 1,252 1,632 2,051 2,417 2,715 3,048 1,908 2,396
Misc. Exp. not W/O
Total Assets 2,020 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,112 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,455
Other Income 109 72 87 101 114 167 184 81 63 68
Total Income 1,221 1,925 2,099 2,067 2,083 2,249 2,336 2,320 2,674 2,523
Total Expenditure -873 -1,474 -1,579 -1,616 -1,468 -1,516 -1,579 -1,526 -1,775 -1,713
PBIDT 349 451 520 451 615 733 757 794 899 810
Interest -1 -2 -1 -2 -1 -2 -11 -15 -11 -12
Depreciation -8 -131 -58 -63 -66 -71 -103 -109 -115 -115
Taxation -119 -138 -165 -180 -188 -231 -133 -171 -160 -102
Exceptional Items -111 10 130 -136
PAT 221 70 305 337 360 429 509 498 613 445
Adjusted EPS 74 15 67 74 79 94 111 109 134 97

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -16 132 113 345 329 332 98 323 427 667
Cash Fr. Inv. 626 103 -89 -701 -250 -238 35 1,530 -469 -575
Cash Fr. Finan. -43 -1,360 -1 -62 -83 -110 -110 -164 -1,571 -181
Net Change 567 -1,125 23 -417 -3 -17 23 1,690 -1,613 -88
Cash & Cash Eqvt 1,433 308 488 71 68 51 74 1,764 151 63

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92
Public 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 10 Aug 2022
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company hereby wishes to notify that Mr. S. Sridhar Managing Director has expressed his intention to take an early retirement and has tendered his resignation as the Managing Director of the Company. Mr. Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification selection and transition to the new leadership takes place in the Company. The effective date of his resignation shall be as agreed between Mr. Sridhar and the Board of Directors and the same will be notified to you separately.Request you to please take the above on record.
Fri, 05 Aug 2022
Board Meeting Outcome for Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30 2022.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations 2015 we submit herewith the unaudited financial results for the quarter
ended June 30 2022 which were approved by the Board of Directors of the Company at its
Meeting held today that commenced at 12:00 noon and concluded at 2:45 p.m.
Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok
& Co LLP in respect of the above results.
Fri, 05 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agent of the Company KFin Technologies Limited has received a request for issue of duplicate Share Certificate(s) from Shareholder(s)

Technical Scans View Details >>

Fri, 12 Aug 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase 5 Years High Increase 5 Years
Closing Near 100 SMA Closing Near 100 SMA
5 SMA Crossing 20 SMA From Above 5 SMA Crossing 20 SMA From Above
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Pfizer Ltd.

Can I Buy Pfizer Shares now?

What is the Share Price of Pfizer?

What is the Relative Strength Index (RSI) Value of Pfizer?

What is the Market Capital (MCAP) of Pfizer?

What are the key metrics to analyse Pfizer?

What is the Price Performance of Pfizer?